Evelo Biosciences Analysis
| EVLODelisted Stock | USD 8.23 2.68 24.56% |
Evelo Biosciences is overvalued with Real Value of 6.32 and Hype Value of 8.23. The main objective of Evelo Biosciences pink sheet analysis is to determine its intrinsic value, which is an estimate of what Evelo Biosciences is worth, separate from its market price. There are two main types of Evelo Biosciences' stock analysis: fundamental analysis and technical analysis.
The Evelo Biosciences pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Evelo |
Evelo Pink Sheet Analysis Notes
About 83.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 15.64. Evelo Biosciences had not issued any dividends in recent years. The entity had 1:20 split on the 30th of June 2023. Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Evelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.The quote for Evelo Biosciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To learn more about Evelo Biosciences call Balkrishan Gill at 617 577 0300 or check out https://www.evelobio.com.Evelo Biosciences Investment Alerts
| Evelo Biosciences is not yet fully synchronised with the market data | |
| Evelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (114.53 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Evelo Biosciences currently holds about 92.01 M in cash with (101.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. | |
| Over 83.0% of the company shares are held by institutions such as insurance companies |
Evelo Biosciences Upcoming and Recent Events
Earnings reports are used by Evelo Biosciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Evelo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 7 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evelo Biosciences's market, we take the total number of its shares issued and multiply it by Evelo Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Evelo Biosciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Evelo Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Evelo Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Evelo Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Evelo Biosciences Outstanding Bonds
Evelo Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Evelo Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Evelo bonds can be classified according to their maturity, which is the date when Evelo Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US29977LAA98 Corp BondUS29977LAA98 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| US29977GAA04 Corp BondUS29977GAA04 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Evelo Biosciences Predictive Daily Indicators
Evelo Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Evelo Biosciences pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Evelo Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Evelo Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evelo shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Evelo Biosciences. By using and applying Evelo Pink Sheet analysis, traders can create a robust methodology for identifying Evelo entry and exit points for their positions.
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. Evelo Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Evelo Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Evelo Pink Sheet
If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |